<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-pathogens-09-00137">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Anastasiou</surname>
    <given-names>O.E.</given-names>
   </name>
   <name>
    <surname>Widera</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Verheyen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Korth</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gerken</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Helfritz</surname>
    <given-names>F.A.</given-names>
   </name>
   <name>
    <surname>Canbay</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wedemeyer</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ciesek</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodies</article-title>
  <source>J. Clin. Virol.</source>
  <year>2017</year>
  <volume>93</volume>
  <fpage>46</fpage>
  <lpage>52</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jcv.2017.06.001</pub-id>
  <pub-id pub-id-type="pmid">28622640</pub-id>
 </element-citation>
</ref>
